Supply Chain
New research from Advisory Board, conducted in partnership with Staples Business, reveals how 102 health system supply chain and executive…
Intarcia Therapeutics, a biopharmaceutical company based in Boston, laid off 60 employees and terminated two late-stage trials of its lead diabetes treatment, reports the Boston Business Journal.
The College of Healthcare Information Management Executives penned a letter Feb. 6 to FDA Commissioner Scott Gottlieb, MD, to recommend the agency exempt certain health IT software from its oversight of clinical decision support solutions.
Supply chains stuck in traditional inventory management practices are fraught with high costs, waste and inefficiencies.
The FDA on Wednesday approved Gilead Sciences' HIV drug Biktarvy, reports Reuters.
Sanofi Genzyme will lay off 130 workers this week at its manufacturing plant in Boston in an effort to reduce costs and simplify operations, according to the Boston Globe.
The Clinical Decision Support Coalition penned a 21-page letter Feb. 5 urging the FDA to rewrite its guidance on clinical decision support software to avoid "overregulation."
The ongoing shortage of IV saline solutions, exacerbated by a relentless flu season and manufacturing disruptions of IV mini-bags following Hurricane Maria, is causing care costs to rise in Wisconsin, reports the Wisconsin Public Radio.
Allergan recorded strong financial performance in the fourth quarter of fiscal year 2017, which ended Dec. 31.
Drug stores and pharmacy chains nationwide are experiencing spot shortages of Tamiflu and its generic version amid a severe flu season, reports Georgia Health News.
The North Carolina Department of Transportation submitted a proposal to test using drones to deliver medical supplies to hard-to-reach areas in the state, reports WRAL.